On A Positive Note: Pittsburgh Photographer Helps Kids With Cancer Feel Like Superstars PITTSBURGH (KDKA) — A local photographer is helping kids with cancer feel like superstars. Costumes, cameras, flashing lights and laughter — what kid wouldn’t want to be treated like a superstar for a day? For kids battling cancer, it’s a welcome diversion […]
Read More
SUO 2020: Clinical Application for Novel Biomarkers in Testis Cancer (UroToday.com) As part of the panel discussion on biomarkers in testis cancer, Dr. Nabil Adra discussed the clinical application of these biomarkers. Dr. Adra notes that AFP, beta-HCG, and LDH are currently the only suitable biomarkers for testis cancer, which are elevated in ~60% of patients […]
Read More
Initial active treatment of localised prostate cancer tied to worse Qol in long run: BMJ Initial active treatment of localised prostate cancer tied to worse Qol in long run: BMJ Top We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. […]
Read More
Bone Cancer Drug Market 2020 Disclosing Latest Trends and Advancement Outlook 2026 Along … Another business knowledge report released by Data Bridge Market Research with title “Worldwide Bone Cancer Drug Market Status and Forecast (2019-2026) by Region, Product Type and End-Use” has capacities to raise as the most huge market worldwide as it has remained […]
Read More
Amgen : BiTE® 101 Cancer treatments have traditionally fit into one of three categories: chemotherapy, surgery or radiation. In recent years, new approaches and innovative modalities – such as immuno-oncology or therapies targeting specific genetic mutations – have started to reshape how oncologists think about treating many cancers. Amgen has been serving cancer patients for […]
Read More
Venclexta With Velcade and Dexamethasone May Improve Progression-Free Survival in Relapsed … Treatment with Venclexta (venetoclax), in addition to Velcade (bortezomib) and dexamethasone, significantly improved progression-free survival (PFS) in patients with relapsed or refractory multiple myeloma (MM) compared with placebo, according to results of the BELLINI trial published in The Lancet Oncology. Despite this significant […]
Read More